Aadi Bioscience, Inc.
AADI
$2.00
-$0.12-5.66%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 6.33M | 5.96M | 6.20M | 5.87M | 5.23M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.33M | 5.96M | 6.20M | 5.87M | 5.23M |
| Cost of Revenue | 13.70M | 12.59M | 1.86M | 11.49M | 9.59M |
| Gross Profit | -7.37M | -6.63M | 4.34M | -5.62M | -4.37M |
| SG&A Expenses | 10.35M | 11.22M | 11.78M | 11.21M | 11.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.04M | 23.81M | 25.75M | 22.69M | 20.70M |
| Operating Income | -17.71M | -17.85M | -19.55M | -16.83M | -15.47M |
| Income Before Tax | -16.27M | -16.30M | -17.97M | -15.22M | -13.92M |
| Income Tax Expenses | -- | -- | -- | -- | -9.00K |
| Earnings from Continuing Operations | -16.27M | -16.30M | -17.97M | -15.22M | -13.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.27M | -16.30M | -17.97M | -15.22M | -13.91M |
| EBIT | -17.71M | -17.85M | -19.55M | -16.83M | -15.47M |
| EBITDA | -17.67M | -17.81M | -19.50M | -16.79M | -15.43M |
| EPS Basic | -0.60 | -0.61 | -0.67 | -0.57 | -0.52 |
| Normalized Basic EPS | -0.38 | -0.38 | -0.42 | -0.35 | -0.32 |
| EPS Diluted | -0.60 | -0.61 | -0.67 | -0.57 | -0.52 |
| Normalized Diluted EPS | -0.38 | -0.38 | -0.42 | -0.35 | -0.32 |
| Average Basic Shares Outstanding | 26.97M | 26.95M | 26.88M | 26.86M | 26.84M |
| Average Diluted Shares Outstanding | 26.97M | 26.95M | 26.88M | 26.86M | 26.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
